GSK takes AMR message to Paddington, bearing responsibility for raising awareness of risks
December 2, 2024After temporary reprieve, Advanz Pharma’s liver med Ocaliva loses marketing nod in Europe
December 2, 2024FDA considers ‘regulatory action’ for bluebird’s Skysona after blood cancer reports
kdunleavy
Mon, 12/02/2024 – 10:43
